Acadia Pharmaceuticals | ACAD - Pe Kurs-Gewinn

Aktienkurs
21.96
Täglich Wechseln
-0.15 -0.68%
Monatlich
-0.23%
Jährlich
49.08%
Q2 Prognose
21.49




Pe Veränderung Datum
Acadia Pharmaceuticals 11.61 2.09 2025-12
ALKERMES 19.54 4.64 2025-12
Alnylam Pharmaceuticals 170.7 367.33 2025-12
Biogen 14.02 4.63 2025-12
BioMarin Pharmaceutical 19.24 0.21 2025-12
Bristol-Myers Squibb 9.28 1.04 2025-12
Cara Therapeutics 27.77 117.09 2021-09
Corcept Therapeutics 41.9 52.28 2025-12
Eisai 26.63 0.46 2025-12
Eli Lilly 40.21 9.66 2025-12
Incyte 14.84 2.79 2025-12
J&J 24.53 0.91 2026-03
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 835.47 802.2 2025-12
Pfizer 14.48 5.18 2025-12
Prothena 22.11 11.37 2022-03
PTC Therapeutics 9.98 3.25 2025-12
Sarepta Therapeutics 27.27 0 2025-09
Vanda Pharmaceuticals 16.79 7.07 2023-06
Vertex Pharmaceuticals 26.15 2.22 2025-12